Literature DB >> 12746891

Endothelin and endothelin receptor antagonists in systemic rheumatic disease.

Maureen D Mayes1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746891     DOI: 10.1002/art.10895

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  28 in total

Review 1.  Scleroderma renal crisis: new insights and developments.

Authors:  Elisa Y Rhew; Walter G Barr
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

Review 2.  Targeted therapy for systemic sclerosis: how close are we?

Authors:  Manuel Ramos-Casals; Vicent Fonollosa-Pla; Pilar Brito-Zerón; Antoni Sisó-Almirall
Journal:  Nat Rev Rheumatol       Date:  2010-04-13       Impact factor: 20.543

3.  Persistent rash on the face and lips.

Authors:  Aaron Samsula; M Alan Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-10

4.  Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis.

Authors:  M E Hettema; D Zhang; H Bootsma; C G M Kallenberg
Journal:  Ann Rheum Dis       Date:  2007-10       Impact factor: 19.103

Review 5.  New lines in therapy of Raynaud's phenomenon.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2008-11-27       Impact factor: 2.631

6.  The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function.

Authors:  Alma Cypiene; Aleksandras Laucevicius; Algirdas Venalis; Jolanta Dadoniene; Ligita Ryliskyte; Zaneta Petrulioniene; Milda Kovaite; Jonas Gintautas
Journal:  Clin Rheumatol       Date:  2008-07-25       Impact factor: 2.980

Review 7.  Endothelin B receptor, a new target in cancer immune therapy.

Authors:  Lana E Kandalaft; Andrea Facciabene; Ron J Buckanovich; George Coukos
Journal:  Clin Cancer Res       Date:  2009-06-30       Impact factor: 12.531

8.  Antiphospholipid antibodies in systemic sclerosis: a double oxidative hit?

Authors:  Paul R J Ames
Journal:  Clin Rheumatol       Date:  2009-06-10       Impact factor: 2.980

9.  Inflammatory murine skin responses to UV-B light are partially dependent on endothelin-1 and mast cells.

Authors:  Martin Metz; Verena Lammel; Bernhard F Gibbs; Marcus Maurer
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

10.  Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-α in the induction of endothelin system genes.

Authors:  Paula B Donate; Thiago M Cunha; Waldiceu A Verri; Cristina M Junta; Flavia O Lima; Silvio M Vieira; Rafael S Peres; Karina F Bombonato-Prado; Paulo Louzada; Sergio H Ferreira; Eduardo A Donadi; Geraldo A S Passos; Fernando Q Cunha
Journal:  Inflamm Res       Date:  2012-01-17       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.